Skip to main content
# Title Department Research Year
341 CK2 Inhibition, Lipophilicity and Anticancer Activity of New N1 Versus N2-Substituted Tetrabromobenzotriazole Regioisomers 2020
342 Studies on the selectivity of proline hydroxylases reveal new substrates including bicycles Department of Pharmacognosy 2020
343 Design, synthesis and antitrypanosomal activity of heteroaryl-based 1,2,4-triazole and 1,3,4-oxadiazole derivatives Department of Pharmaceutical Organic Chemistry 2020
344 Design and Synthesis of Novel quinoline/chalcone/1,2,4-triazole hybrids as potent antiproliferative agent targeting EGFR and BRAFV600E kinases Department of Pharmaceutical Organic Chemistry 2020
345 Towards understanding of different solid forms of formoterol fumarate: Combined computational and experimental approach Department of Pharmaceutical Analytical Chemistry 2020
346 Pencil Graphite Electrode Decorated with Xylenol Orange Flakes for Studying Possible Pharmacokinetic Interaction Between Vardenafil and Daclatasvir Department of Pharmaceutical Analytical Chemistry 2020
347 Chemical Composition and Biological Activity of Capetula and Shoots Essential Oils of Senecio
glaucus L.
Department of Pharmacognosy 2020
348 Evaluation of autophagy-related genes in Egyptian systemic
lupus erythematosus patients
2020
349 Further Insight Into the Dual COX-2 and 15-LOX Anti-Inflammatory Activity of 1,3,4-Thiadiazole-thiazolidinone Hybrids: The Contribution of the Substituents at 5th Positions is Size Dependent Department of Pharmaceutical Organic Chemistry 2020
350 Combining acetyl salicylic acid and rofecoxib into novel oral tablets normalize platelet function with potential higher tolerability in patients with cardiovascular disorders 2020